Public Management

Rwanda: Construction works for Africa’s first ARNm vaccine factory kicked-off

Rwanda: Construction works for Africa’s first ARNm vaccine factory kicked-off
Friday, 24 June 2022 21:33

In Africa, there is a growing number of initiatives to boost the local medicine production capabilities. In the same wake, leaders and international partners want to increase the number of vaccine factories on the continent. 

German pharmaceutical company BioNTech recently launched the construction of Africa's first modular messenger RNA (mRNA) vaccine manufacturing facility. It disclosed the event in a release published on its website last Thursday.  

Covering 30,000 square meters, the facility will initially be equipped with two BioNTainers, scheduled for completion by the end of 2022. It will employ nearly 100 people in the next two years.  

According to the release, the BioNTainers will specialize in the production  of "a range of mRNA-based vaccines targeted to the needs of the African Union member states, which could conceivably include the Pfizer-BioNTech COVID-19 vaccine and BioNTech's investigational malaria and tuberculosis vaccines, if they are successfully developed, approved or authorized by regulatory authorities.” They will produce approximately 50 million doses of Pfizer-BioNTech covid-19 vaccine per year and may also quick off the human stage of the malaria vaccine trial this year.  

"The company expects to set up additional factories in Senegal and South Africa in close coordination with its partners in the respective countries. The initial site will become a node in a decentralized and robust African end-to-end manufacturing network. All vaccines to be manufactured in the network will be dedicated to people residing in member states of the African Union," the release adds.

The German pharmaceutical company first announced an agreement with Rwanda and Senegal to build vaccine production plants last October 2021. It aims to create a continental network that will enable the production of millions of vaccines every year. 

This initiative comes at a time when African authorities are planning to strengthen the local production of pharmaceutical products. Currently, the continent manufactures about 1% of the vaccines it uses and the Africa Union wants to increase that percentage to 60% by 2040. 

Jean-Marc Gogbeu

Additional Info

  • communiques: Non
  • couleur: N/A
On the same topic
Creditinfo licensed to operate credit bureau across six CEMAC countries Bureau to collect borrower data, expand regional credit information...
EGX is consulting on a revised trading schedule, extending the close to 3:00 PM and adjusting the opening to increase overlap with Gulf...
Scheme helps banks finance farming, processing and exports deemed too risky Agriculture accounts for just 3.95% of private sector bank lending...
Kenyan banks face a potential $800M payout after courts ruled unapproved interest rate hikes illegal, reinforcing consumer protection...
Most Read
01

The BCID-AES launches with 500B CFA to fund Sahel infrastructure, asserting sovereignty from the B...

AES Launches Confederal Investment Bank: A Strategic Pivot Toward Sahelian Financial Sovereignty
02

Nomba brings Apple Pay to 300k Nigerian shops. Following Paystack, this "second row" move enables ...

Beyond Online Checkouts: Apple Pay Finds a Second Row into Nigeria via Nomba
03

Kenya shipped its first mango consignment to the UK on December 20 The move is part of a pilo...

Kenya targets UK market to boost mango exports
04

Kenya’s CMA licensed Safaricom and Airtel Money as Intermediary Service Platform Providers (ISPPs)...

Safaricom and Airtel Money Licensed to Facilitate Capital Markets Access in Kenya
05

NALA has secured PSP and PSO licenses from the Bank of Uganda, adding to its 2024 Money Remittance...

NALA Secures Triple Licensing in Uganda, Accelerating East African Fintech Expansion
Enter your email to receive our newsletter

Ecofin Agency provides daily coverage of nine key African economic sectors: public management, finance, telecoms, agribusiness, mining, energy, transport, communication, and education.
It also designs and manages specialized media, both online and print, for African institutions and publishers.

SALES & ADVERTISING

regie@agenceecofin.com 
Tél: +41 22 301 96 11 
Mob: +41 78 699 13 72


EDITORIAL
redaction@agenceecofin.com

More information
Team
Publisher

ECOFIN AGENCY

Mediamania Sarl
Rue du Léman, 6
1201 Geneva
Switzerland

 

Ecofin Agency is a sector-focused economic news agency, founded in December 2010. Its web platform was launched in June 2011. ©Mediamania.

 
 

Please publish modules in offcanvas position.